The goal of this randomized controlled trial is to investigate the difference between LPC (mini-midline) and PIVC (peripheral venous catheter) on the need of further venipuncture for blood withdrawal or placement of a new vascular access. The main questions it aims to answer are: * Whether the number of patients with LPC and PIVC differ in terms of repeated venipunctures; * Whether the number of patients with LPC and PIVC differ in terms of adverse events associated with the use of such vascular catheters. Researchers will compare the proportion of patients with repeated venipunctures between LPC and PIVC arms.
A standard peripheral intravenous catheter (PIVC) or a mini-midline (LPC) will be placed according to routine clinical indications (i.e., for blood withdrawal and IV drug therapy) in patients seeking care at the Emergency Department. On admission at the Emergency Department triage desk, patients will be assigned a triage code according to clinical assessment by the triage nurse and will be evaluated as to the probability of being eventually admitted to hospital. Following enrollment, patients will be randomly assigned to receive LPC or PIVC. The follow-up period begins after catheter placement and continues through transfer to a hospital ward. During this period of catheter management, the insertion site and dressing will be monitored.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Enrollment
294
PowerGlide Pro™ Midline Catheter
Venflon™ Pro Safety Needle Protected IntraVenous Cannula
Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico
Milan, Italy
Difference in proportion
Difference between the two study arms in the proportion of patients who required a venipuncture after insertion of the PIVC or the LPC.
Time frame: The catheter will be evaluated within 24 hours after the placement
Adverse events associated with use of LPC and PIVC
Number of adverse events (e.g., thrombophlebitis, extravasation, inflammation of the insertion site) monitored also using the Visual Infusion Phlebitis Score
Time frame: Adverse will be evaluated every 24 hours till the catheter removal
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.